1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Johnson & Johnson

Johnson & Johnson

JNJ
Johnson & JohnsonUS flagNew York Stock Exchange
248.82
USD
-4.22
- -
598.96BMarket Cap

Total Valuation

Johnson & Johnson carries a market capitalization of 598.96B, placing it among publicly traded companies globally. Its enterprise value stands at 611.44B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap598.96B
Enterprise Value611.44B

Valuation Ratios

Johnson & Johnson trades at a trailing price-to-earnings ratio of 39.44.

PE Ratio39.44
PS Ratio8.42
PB RatioN/A
P/TBV RatioN/A
P/FCF Ratio26.86
P/OCF Ratio32.19

Enterprise Valuation

On an enterprise value basis, Johnson & Johnson trades at an EV/EBITDA multiple of 24.58 and an EV/FCF ratio of 25.84. The EV/Sales ratio of 8.42 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 32.04 provides insight into valuation relative to core operating earnings.

EV / Sales8.42
EV / EBITDA24.58
EV / EBIT32.04
EV / FCF25.84

Financial Position

Johnson & Johnson maintains a current ratio of 3.13, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 184.28, indicating elevated leverage, while an interest coverage ratio of 34.03 demonstrates strong ability to service its debt obligations.

Current Ratio3.13
Quick Ratio2.25
Debt / Equity184.28
Debt / EBITDAN/A
Interest Coverage34.03

Financial Efficiency

Johnson & Johnson posts a return on equity of 993.78 and a return on invested capital of 24.53.

Return on Equity (ROE)993.78
Return on Assets (ROA)16.03
Return on Invested Capital (ROIC)24.53
Return on Capital Employed (ROCE)59.83
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.49

Taxes

Over the trailing twelve months, Johnson & Johnson has paid 2.95B in income taxes, reflecting an effective tax rate of 15.97.

Income Tax2.95B
Effective Tax Rate15.97

Stock Price Statistics

Johnson & Johnson's stock has gained approximately 51.3872% over the past 52 weeks. The 50-day moving average sits at 238.66, while the 200-day moving average is 222.92.

Beta (5Y)N/A
52-Week Price Change51.3872%
50-Day Moving Average238.66
200-Day Moving Average222.92
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Johnson & Johnson generated 72.62B in revenue and converted that into 15.50B in net income, yielding earnings per share of 6.36. EBITDA reached 24.87B, while operating income came in at 19.08B.

Revenue72.62B
Gross Profit49.24B
Operating Income19.08B
Pretax Income18.45B
Net Income15.50B
EBITDA24.87B
EBIT19.08B
Earnings Per Share (EPS)6.36

Cash Flow

Johnson & Johnson produced 18.99B in operating cash flow over the past twelve months. After subtracting -4.06B in capital expenditures, free cash flow totaled 14.93B - equivalent to 6.20 per share.

Operating Cash Flow18.99B
Capital Expenditures-4.06B
Free Cash Flow14.93B
FCF Per Share6.20

Margins

Johnson & Johnson operates with a gross margin of 67.81, reflecting its pricing power and cost economics. The operating margin of 26.28 and net profit margin of 21.35 provide insight into operational efficiency.

Gross Margin67.81
Operating Margin26.28
Pretax Margin25.41
Profit Margin21.35
EBITDA Margin34.25

Dividends & Yields

The company's payout ratio of 60.59 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share3.90
Dividend YieldN/A
Payout Ratio60.59
Shareholder Yield1.60
FCF Yield3.72

Stock Splits

Johnson & Johnson's most recent stock split took place on June 13, 2001 with a 1:2 split ratio.

Last Split Date6/13/2001
Split Ratio1:2

Scores

Johnson & Johnson posts an Altman Z-Score of 13.25, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score13.25